Literature DB >> 28078568

Rediagnosing one of Smith's patients (John McCann) with "neuromas tumours" (1849).

Martino Ruggieri1, Andrea D Praticò2,3, Rosario Caltabiano4, Agata Polizzi5,6.   

Abstract

In 1849, the Irish Professor of Surgery, Sir Robert William Smith, by publishing his "Treatise on the Pathology, Diagnosis and Treatment of Neuroma", collected six previous examples of "general development of neuromatous tumours" and reported three further cases (two personal and one referred) of what is nowadays known as neurofibromatosis. Among these latter cases, there was a 35-year-old cattle-driver, John McCann, who was first admitted at hospital in 1840 because of a large tumour on the right side of his neck thought to be malignant (and a second tumour sublingually) but not operated. McCann was readmitted in 1843 ("in an emaciated state"), because of an immense tumour in his thigh dying few months later "with hepatic symptoms". Smith's post-mortem examination revealed dozens of smaller additional tumours. Based on application of modern diagnostic criteria (to McCann's portrait at second referral) and on pathological grounds (reconsideration of the histopathological report of McCann's neuroma of the thigh), we tentatively hypothesise that this patient could be the earliest (illustrated) example of either: (1) a malignant peripheral nerve sheath tumour (MPNST); (2) neurofibromatosis type 2 (NF2); or (3) schwannomatosis (SWNTS). The progressively enlarging masses, the emaciated state and the later death are in favour of a MPNST (against is the lack of malignant appearance at histopathology); the clinical (and gross pathological) appearance of the tumours as large, rounded, encapsulated, eccentric lesions deflecting the parent nerve over the surface of the tumour is typical of schwannomas (thus, in favour of NF2 or SWTNS). Whatever diagnosis we could consider these tumours could be secondary to a (local) mosaic loss of heterozygosity and ultimately represent type 2 segmental manifestations superimposed on an ordinary autosomal dominant trait (i.e., NF1, NF2 or SWTNS).

Entities:  

Keywords:  Early history; NF1; NF2; Neuroma; Neuromata; Schwannomatosis; Smith

Mesh:

Year:  2017        PMID: 28078568     DOI: 10.1007/s10072-016-2797-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  23 in total

1.  Neurofibromatosis: why not Smith's disease?

Authors:  J B Lyons; H Staunton
Journal:  J Hist Neurosci       Date:  1992-01       Impact factor: 0.529

2.  From Aldrovandi's "Homuncio" (1592) to Buffon's girl (1749) and the "Wart Man" of Tilesius (1793): antique illustrations of mosaicism in neurofibromatosis?

Authors:  M Ruggieri; A Polizzi
Journal:  J Med Genet       Date:  2003-03       Impact factor: 6.318

Review 3.  The clinical and diagnostic implications of mosaicism in the neurofibromatoses.

Authors:  M Ruggieri; S M Huson
Journal:  Neurology       Date:  2001-06-12       Impact factor: 9.910

4.  Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.

Authors:  M Ruggieri; P Iannetti; A Polizzi; I La Mantia; A Spalice; O Giliberto; N Platania; A L Gabriele; V Albanese; L Pavone
Journal:  Neuropediatrics       Date:  2005-02       Impact factor: 1.947

5.  Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis.

Authors:  Miriam J Smith; Anjana Kulkarni; Cecilie Rustad; Naomi L Bowers; Andrew J Wallace; Susan E Holder; Arvid Heiberg; Richard T Ramsden; D Gareth Evans
Journal:  Am J Med Genet A       Date:  2011-11-21       Impact factor: 2.802

6.  Mosaic (segmental) neurofibromatosis type 1 (NF1) and type 2 (NF2): no longer neurofibromatosis type 5 (NF5).

Authors:  M Ruggieri
Journal:  Am J Med Genet       Date:  2001-06-15

Review 7.  Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.

Authors:  Martino Ruggieri; Andrea Domenico Praticò; Dafydd Gareth Evans
Journal:  Semin Pediatr Neurol       Date:  2015-10-28       Impact factor: 1.636

8.  Robert William Smith: his life and his contributions to medicine.

Authors:  Hriday M Shah; Kevin C Chung
Journal:  J Hand Surg Am       Date:  2008 Jul-Aug       Impact factor: 2.230

9.  Revisiting neurofibromatosis type 2 diagnostic criteria to exclude LZTR1-related schwannomatosis.

Authors:  Miriam J Smith; Naomi L Bowers; Michael Bulman; Carolyn Gokhale; Andrew J Wallace; Andrew T King; Simon K L Lloyd; Scott A Rutherford; Charlotte L Hammerbeck-Ward; Simon R Freeman; D Gareth Evans
Journal:  Neurology       Date:  2016-11-16       Impact factor: 9.910

Review 10.  Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies.

Authors:  M Ruggieri; A D Praticò; A Serra; L Maiolino; S Cocuzza; P Di Mauro; L Licciardello; P Milone; G Privitera; G Belfiore; M Di Pietro; F Di Raimondo; A Romano; A Chiarenza; M Muglia; A Polizzi; D G Evans
Journal:  Acta Otorhinolaryngol Ital       Date:  2016-10       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.